-
Alembic Pharma Q1 net profit declines to Rs 165 cr
expresspharma
July 29, 2021
The company had posted a net profit of Rs 301.46 crores for the corresponding period of the previous fiscal, Alembic Pharmaceuticals said in a regulatory filing.
-
Lincoln Pharmaceuticals reports 28.33 per cent rise in standalone net profit in Q4 FY21
expresspharma
May 26, 2021
Lincoln Pharmaceuticals has reported net profit of Rs 11.85 crores in Q4FY21 as against the net profit of Rs 9.23 crores in the corresponding period last year, growth of 28.33 per cent.
-
HanAll Biopharma Reports First Quarter 2021 Financial Results
prnasia
May 07, 2021
HanAll Biopharma announced on the 29th, Apr. that it achieved 27.8 billion won in sales, 5.4 billion won in operating profit and 4.5 billion won in net profit in the first quarter of this year.
-
Novo Nordisk reports increased Q1 2021 profit
pharmaceutical-technology
May 07, 2021
The operating profit of Novo Nordisk decreased by 8% in local currency from kr16.3bn ($2.63bn) in last year’s quarter to kr14.9bn ($2.4bn) this quarter but increased by 3% at constant exchange rates (CER).
-
Strides Pharma Q3 net profit declines 62 per cent to Rs 35 cr
expresspharma
February 05, 2021
The company also announced strengthening of its global executive management team to sharpen its focus on key business growth areas.
-
Ajanta Pharma posts jump in consolidated PAT to Rs176.63 crores in Q3 FY2020-21
expresspharma
February 03, 2021
Ajanta Pharma has reported financial results for the period ended December 31, 2020.
-
Neuland Laboratories Q3FY21 consolidated PAT rises to Rs 26.73 crore
expresspharma
February 03, 2021
The driver of this quarter's CMS uptick has been the strong performance from the scaleup projects which have contributed to the revenues.
-
Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales
prnasia
January 26, 2021
Samsung Biologics reported its fourth quarter and full-year 2020 financial results indicating strong business performance, benefitting from increased sales across all plants and significant business agility and operating excellence in overcoming ...
-
GSK Pharma announces results for the quarter ended June 30, 2020
expresspharma
July 30, 2020
GlaxoSmithKline Pharmaceuticals declared its financial results for the quarter ended June 30, 2020. Revenue for the quarter came in at Rs 649 crores as against Rs 787.97 crores for the same period last year.
-
Biocon releases Q1FY21 results; Revenue up by 14 per cent at Rs 1,690 Cr
expresspharma
July 27, 2020
The company's Research Services business reported flat revenue growth at Rs 422 Crore due to slowdown of operations impacted by the COVID-19 crisis.